Structure via PubChem · Public domain (PubChem)
Chemical data
- Formula
- C56H98N16O13
- Molecular weight
- 1203.5 g/mol
- IUPAC name
- N-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide
- SMILES
- CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O
- InChIKey
- WQVJHHACXVLGBL-UHFFFAOYSA-N
- XLogP
- -2.5
- Polar surface area
- 491 Ų
- H-bond donors
- 18
- H-bond acceptors
- 18
- Formal charge
- 0
via PubChem
Research
7,997 papers- Clinical Use of Polymyxin B.Advances in experimental medicine and biology · 2019
- Polymyxin B versus colistin: an update.Expert review of anti-infective therapy · 2015
- Polymyxin B and silver nanoparticles: a nanotechnology-driven approach to overcome antibiotic resistance.Drug development and industrial pharmacy · 2025
- Polymyxin B accelerates the α-synuclein aggregation.Biophysical chemistry · 2021
- Polymyxin B hemoperfusion: a mechanistic perspective.Critical care (London, England) · 2014
via PubMed